Lenvatinib, Pembrolizumab Plus TACE Improves PFS in Intermediate-Stage HCC

Press/Media

Period15 Sep 2024

Media coverage

1

Media coverage

  • TitleLenvatinib, Pembrolizumab Plus TACE Improves PFS in Intermediate-Stage HCC
    Media name/outletOncology Nursing News
    Country/TerritoryUnited States
    Date15/09/24
    PersonsJosep Llovet
View all 1
View less